Veterinary Dermatology Market: Growth, Size, Share, and Trends

Report Code MD 9319
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030

Overview

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, reaching US$20.11 billion in 2025 and an impressive US$30.31 billion by 2030. The Veterinary Dermatology Market is for therapeutic products that assist in the management of a range of skin diseases in pets from allergies to fungal and bacterial infections, irritations, parasitic infestations, atopic dermatitis, chronic skin disease, and even skin cancer. The market is for companion animals and livestock, with treatment from topical creams to oral tablets and injectables. The products not only treat skin disease, but also maintain the health of the skin, maintaining the quality of the coat, and the health of the animal. Advances in veterinary dermatology are leading to more advanced treatments that are more effective and targeted to skin-related disorders.

The major factors that are driving the growth of this market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure. The opportunities in the market are, technological advancements and product launches, high growth potential in emerging economies, surging number of veterinary practitioners in developed markets.

Veterinary Dermatology Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Veterinary Dermatology Market

Asia Pacific

Market growth in the Asia Pacific region can be attributed to rise in the disposable income, government initiatives to promote animal welfare, and increasing awareness among pet owners and farmers. The rising incidence of infectious diseases is also expected to fuel the uptake of advanced respiratory diagnostics during the forecast period.

Factors such as increasing trend of pet ownership, increased adoption of pet insurance, and surging number of veterinary practitioners are expected to drive market growth during the forecast period.

Technological advancements, product launches, collaborations, partnerships, and agreements are set to offer attractive growth opportunities for market participants in the near future.

The Asia Pacific veterinary dermatology market is expected to be worth USD 6.34 billion by 2030, growing at the highest CAGR of 9.2% during the forecast period.

The rising pet care costs to restrain the market growth to a certain extent. Also, growing resistance to parasiticides is a major challenge faced in the market.

Global Veterinary Dermatology Market Dynamics

DRIVER: Expanding companion animal population and pet ownership

The veterinary dermatology market is expanding with the rising number of companion animals and pet ownership across the globe. In developed regions such as North America and Europe and developing regions such as India and China, more individuals are keeping pets, and with it comes greater demand for veterinary dermatological services. The American Pet Products Association (APPA) indicated that 86.9 million U.S. households (66%) had a pet during the 2023-2024 period, and the American Veterinary Medical Association (AVMA) indicated an increase in households owning dogs from 31.3 million in 1996 to 59.8 million in 2024. In 2021, about 63.0 million U.S. households had dogs, and 41.8 million had cats as pets. Additionally, as per the European Pet Food Industry Federation (FEDIAF), there is an increase in the number of dogs from 104.34 million in 2022 to 106.36 million in 2023. According to the Indian Dairy Association, India had a cattle population of more than 305 million in 2021, the highest in the world. With more companion animals in need of special skin treatment, the veterinary dermatology market is set to grow and develop in the future.

RESTRAINT: Rising pet care costs

The American Pet Products Association (APPA) reported that the expense for veterinary care ranked second compared to other pet expenses, and the total amount of money spent by consumers in 2024 stands at USD 150.6 billion, which has a projection of reaching USD 200 billion by 2030. The price of prolonged dermatological procedures serve as a primary factor towards this expense. PetMD suggests that an average pet would incur between USD 250 and USD 4,500 for veterinary charges, while specialized veterinarians may claim between USD 5,000 to USD 20,000 for dermatological surgeries. These prices associated with the treatment of skin ailments through immunotherapy, laser surgery, and allergy testing are steep, thus making it expensive for pet owners. Furthermore, these steep expenses negatively impact uninsured pet owners and those from lower socioeconomic backgrounds, thus refraining market growth.

 

OPPORTUNITY: Technological advancements and product launches

Emerging technology and new products are promoting the global economy in the field of veterinary dermatology. Merck & Co., Inc. (U.S.) received an Approval from the European Commission for marketing authorization of BRAVECTO TriUNO (Tablet) in November 2024; this is a new formulation of fluralaner for internal and external parasites in dogs. The product is also authorized in several key markets, including Peru, Guatemala, Nicaragua, and Costa Rica. Similarly, Zoetis Inc. (U.S.) launched Apoquel Chewable (Tablet) for market release in the United States in October 2023-it marks the first chewable formulation for treatment of pruritus and atopic dermatitis in dogs. Such innovations improve the convenience and efficacy of treatment, augment product portfolios and competitive tension in the market. Investing in the development of dermatological products will continue to bring enhanced treatment adherence and accessibility for curing dermatological conditions for pets.

CHALLENGES: Growing resistance to parasiticides

The increasing resistance against available parasiticides has become a major challenge in the animal dermatology, thus treatments for parasitic skin ailments in animals are being affected. Resistance against available antiparasitic agents has grown up due to misuse and overuse, especially macrocyclic lactones and isoxazolines, has emerged among parasites such as fleas, ticks, and mites. This would invariably lead to low treatment success rates, increased dependency on combination therapies, and soaring veterinary costs. The compounding factor in the situation is the slow development rate of new antiparasitic agents, thus leaving the veterinarian with fewer effective choices. North America and Europe, which are characterized by heavy usage of parasiticides, are reporting increasing incidences of such resistance, reflecting an immediate need for sustainable parasite control strategies, including rotational drug use and integrated pest management techniques.

Global Veterinary Dermatology Market Ecosystem Analysis

Leading players in this market include well-established and financially stable service providers of veterinary dermatology products. These companies have been operating in the market for several years and possess a diversified product portfolio, advanced technologies, and strong global presence.

The report segments the veterinary dermatology market by route of administration, product, condition type, animal type, end user, and region.

Veterinary Dermatology Market Ecosystem
 

By route of administration, oral segment witnessed the fastest CAGR during the forecast period.

By route of administration, the market is segmented into Topical, Injectables and Oral. In 2024, the oral segment witnessed the fastest CAGR during the forecast period (2025-2030) in the market. The advantage here arises largely from the fact that oral medications are easier to administer, so compliance from the pet owners is thus higher for oral medication administration than for injectable forms of treatments. Oral medications also afford predictable dosing and absorption into the system, thereby converting into a potent therapy against chronic skin disorders like allergies or infections. Another essential factor in growing the market position of this segment is the increase in the popularity of palatable and flavored oral medications among their pet owners.

By product type, antiparasitic drugs segment accounted for largest market share in 2024.

The market has been divided on the bases of product types into five major segments, such as Antiparasitic, antifungals, antibacterials, monoclonal antibodies, and other product types. In 2024, the largest segment of the antiparasitic drugs remained the major segment in the market. This large share is majorly attributed to the number of instances and occurrences of parasites flea, ticks, and mites, which are among the most identified dermatological conditions in animals. Moreover, the availability of wide range antiparasitic such as spot-on treatments, chewable tablets, and injectables has led to increased animal and owner adoption and use, while further consolidating this segment's position in the market.

By condition type, parasitic infection segment is estimated to grow at highest CAGR during forecast period.

By condition type, the veterinary dermatology market includes parasitic infections, infectious diseases, autoimmune skin diseases, skin cancer and other skin condition types. The parasitic infection segment is estimated to grow at the highest CAGR, owing to the factors such as widespread occurrence of the ectoparasitic infestations and their significant impact on both companion and livestock animal health. Moreover, increasing use of topical ectoparasiticide treatment, and awareness among the pet owners and livestock farmer has also contributed to the segment's market growth.

By animal type, companion animal segment dominated market, in 2024

The market by animal type is divided into two large categories: companion animals and livestock animals. The companion animal segment, as of 2024, has dominated the market with the primary driving force behind this dominance being the rise in the number of canine and feline animals. Additionally, the popularity of veterinary dermatology products among companion animals has been promoted by other forces in the shape of rising pet healthcare expenses and enhanced awareness among pet owners concerning dermatological conditions such as allergies, infection, and dermatitis. Additionally, the segment is also backed by the rising occurrence of sophisticated treatment approaches.

By end user, veterinary hospitals & clinics segment is expected to grow at highest CAGR during forecast period.

Segmented by end users, the market is classified into three broad categories, namely veterinary hospitals & clinics, animal shelters and rescues, and other end users. The veterinary hospitals & clinics segment has seen the highest CAGR in the market during the forecast period. The reason for this growth is primarily because veterinary hospitals & clinics are typically the first point of contact for pet owners and animal caregivers of livestock, and hence the first point of contact for dermatological treatments. Secondly, the increasing incidence of advanced diagnostic machines, specialized dermatology centers, and the increasing number of veterinary professionals also lead the high growth rate of this segment.

North America region dominated the market in 2024.

The market is divided into 5 regions – North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America held the largest market share in 2024. This is mainly due to growing pet population in developed countries like US and Canada and presence of top veterinary dermatology companies in the region. Higher pet healthcare expenditure, advanced veterinary infrastructure and increased awareness about animal dermatological conditions are further driving the demand for veterinary dermatology products and making North America the leader in the market.

HIGHEST CAGR MARKET IN 2024
US FASTEST GROWING MARKET IN THE REGION
Veterinary Dermatology Market Region

Recent Developments of Veterinary Dermatology Market

  • In November 2024, Merck & Co., Inc. (US) received a European Commission grant for marketing authorization of BRAVECTO TriUNO, a new fluralaner formulation for dogs targeting internal and external parasites, also approved in Peru, Guatemala, Nicaragua, and Costa Rica.
  • In November 2024, Bimeda, Inc. (Ireland) expanded of its anti-parasitic portfolio with the launch of MoxiSolv Injection (moxidectin), the FDA-approved injectable, available in non-shattering 500 mL plastic bottle.
  • In September 2024, Norbrook (Ireland) invested USD 1.5 million to officially open the newly upgraded sterile injectable manufacturing cite in Newry, Northern Ireland, to produce products that are critical in treating and preventing infections in livestock and pets.
  • In July 2024, Dechra Pharmaceuticals plc (UK) acquired Invetx (US), which specializes in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).

Key Market Players

Want to explore hidden markets that can drive new revenue in Veterinary Dermatology Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD million/billion)
Segments covered Route of Administration, Product, Condition Type, Animal Type, End user, Region
Geographies covered North America, Europe, Asia Pacific, Latin America

 

Key Questions Addressed by the Report

What are the emerging trends in the veterinary dermatology market?
Rise in pet ownership and humanization of pets, increased focus on pet wellness programs, and rising use of diagnostics and wearable technology for early detection are key market trends.
Which are the segments that have been included in this report?
This report has the following main segments:
  • By Route of administration
  • By Product
  • By Condition Type
  • By Animal Type
  • By End User
  • By Region
Which are the top industry players in the veterinary dermatology market?
The top market players are Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Virbac (France), Zoetis Inc. (US), Boehringer Ingelheim International GmbH (Germany), Vetoquinol (France), and Ceva Sante Animale (France).
What are the factors expected to pose a challenge to the growth of the veterinary dermatology market?
Growing resistance to parasiticides and diversity in parasite species are expected to pose challenges to market growth.
Which is the fastest-growing product segment in the veterinary dermatology market?
The antiparasitic drugs segment is expected to grow with the highest CAGR during the forecast period (2025-2030) due to the increasing incidence of ectoparasitic infestations in animals and rising pet population.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Veterinary Dermatology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
32
RESEARCH METHODOLOGY
37
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
60
MARKET OVERVIEW
64
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Expanding companion animal population and pet ownership
    - Growing concerns about infectious zoonotic diseases
    - Rising awareness initiatives by government and animal welfare organizations
    - Increasing adoption of pet insurance and high animal healthcare expenditure
    RESTRAINTS
    - Rising pet care costs
    - Restrictions on use of parasiticides for food-producing animals
    OPPORTUNITIES
    - Technological advancements and product launches
    - High growth potential in emerging economies
    - Surging number of veterinary practitioners in developed markets
    CHALLENGES
    - Growing resistance to parasiticides
    - Diversity in parasite species
  • 5.3 INDUSTRY TRENDS
    RISE IN PET OWNERSHIP, HUMANIZATION OF PETS, AND INCREASED FOCUS ON PET WELLNESS PROGRAMS
    RISING USE OF DIAGNOSTICS AND WEARABLE TECHNOLOGY FOR EARLY DETECTION
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Topical nanomedicine
    - Biologic therapies
    COMPLEMENTARY TECHNOLOGIES
    - Phototherapy
    - Hydrotherapy
    ADJACENT TECHNOLOGIES
    - Telemedicine platforms
    - Wearable devices
  • 5.5 PORTER’S FIVE FORCES ANALYSIS
    COMPETITIVE RIVALRY
    - Established players
    - Continuous innovation
    BARGAINING POWER OF BUYERS
    - Consolidated veterinary groups
    - Demand for affordable solutions
    BARGAINING POWER OF SUPPLIERS
    - Specialized raw materials
    - Quality compliance
    THREAT OF SUBSTITUTES
    - Limited alternatives
    - Specialized treatments
    THREAT OF NEW ENTRANTS
    - High R&D costs
    - Regulatory requirements
  • 5.6 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR VETERINARY DERMATOLOGY MARKET
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
    IMPORT AND EXPORT SCENARIO FOR VETERINARY DERMATOLOGY PRODUCTS
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE
    AVERAGE SELLING PRICE TREND OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION
  • 5.10 REIMBURSEMENT ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET
  • 5.14 IMPACT OF GENERATIVE AI ON VETERINARY DERMATOLOGY MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    ZOETIS LAUNCHED APOQUEL TABLET FOR ALLERGIC DERMATITIS
    ELANCO LAUNCHED ZENRELIA TABLET FOR CANINE ATOPIC DERMATITIS
    VIRBAC LAUNCHED ALLERDERM SPOT-ON TOPICAL PRODUCT FOR SKIN BARRIER REPAIR
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 VALUE CHAIN ANALYSIS
  • 5.19 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET
  • 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.21 INVESTMENT AND FUNDING SCENARIO
VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION
108
  • 6.1 INTRODUCTION
  • 6.2 TOPICAL
    HIGH PREVALENCE OF ECTOPARASITIC INFESTATIONS AMONG PETS TO DRIVE DEMAND
  • 6.3 INJECTABLES
    RAPID ABSORPTION AND HIGH BIOAVAILABILITY TO FUEL GROWTH OF INJECTABLE PRODUCTS
  • 6.4 ORAL
    COMPREHENSIVE APPROACH TO MANAGING CHRONIC AND SEVERE DERMATOLOGICAL DISORDERS
VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE
117
  • 7.1 INTRODUCTION
  • 7.2 ANTIPARASITIC DRUGS
    HIGH PREVALENCE OF PARASITIC INFECTIONS IN ANIMALS TO DRIVE DEMAND
  • 7.3 ANTIFUNGAL DRUGS
    INCREASING INSTANCES OF YEAST DERMATITIS AND CANDIDIASIS TO DRIVE DEMAND
  • 7.4 ANTIBACTERIAL DRUGS
    GROWTH HINDERED BY RISING CONCERNS OVER ANTIMICROBIAL RESISTANCE
  • 7.5 MONOCLONAL ANTIBODIES
    RISING INVESTMENT IN R&D TO BOOST SEGMENTAL GROWTH
  • 7.6 OTHER PRODUCT TYPES
VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE
131
  • 8.1 INTRODUCTION
  • 8.2 PARASITIC INFECTIONS
    HIGH OCCURRENCE IN BOTH COMPANION AND LIVESTOCK ANIMALS TO DRIVE DEMAND FOR PREVENTIVE MEASURES
  • 8.3 INFECTIOUS DISEASES
    HIGH PREVALENCE OF FUNGAL INFECTIONS TO DRIVE GROWTH
  • 8.4 AUTOIMMUNE SKIN DISEASES
    LOWER OCCURRENCE OF THESE DISEASES CONTRIBUTE TO SMALLER MARKET SHARE
  • 8.5 SKIN CANCER
    GROWING AWARENESS ABOUT IMPORTANCE OF EARLY DETECTION AND TREATMENT OF SKIN CANCER TO DRIVE GROWTH
  • 8.6 OTHER CONDITION TYPES
VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE
142
  • 9.1 INTRODUCTION
  • 9.2 COMPANION ANIMALS
    DOGS
    - Growing dog population and high pet ownership to drive growth
    CATS
    - Growing awareness of feline health to drive growth
    HORSES
    - Initiatives related to adoption to drive growth
    OTHER COMPANION ANIMALS
  • 9.3 LIVESTOCK ANIMALS
    CATTLE
    - Economic importance of dairy and beef cattle to drive growth
    SWINE
    - Rising global swine population and pork consumption to drive growth
    POULTRY
    - Increasing demand for milk and dairy products to drive growth
    OTHER LIVESTOCK ANIMALS
VETERINARY DERMATOLOGY MARKET, BY END USER
164
  • 10.1 INTRODUCTION
  • 10.2 VETERINARY HOSPITALS AND CLINICS
    GROWING DEMAND FOR SPECIALIZED SKINCARE AND TREATMENTS TO DRIVE MARKET
  • 10.3 ANIMAL SHELTERS AND RESCUES
    NGO AND ANIMAL WELFARE ORGANIZATIONS TO KEEP SUPPORTING DERMATOLOGICAL TREATMENT IN VETERINARY MARKET
  • 10.4 OTHER END USERS
VETERINARY DERMATOLOGY MARKET, BY REGION
171
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK
    US
    - High pet ownership rates to drive growth
    CANADA
    - Rising concerns about pet skin health to drive market
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK
    GERMANY
    - Rising poultry consumption and dairy industry to drive market
    UK
    - Large pet ownership and zoonotic disease prevention to drive market
    FRANCE
    - Stable animal healthcare spending to support market growth
    ITALY
    - Expanding livestock industry to drive market
    SWITZERLAND
    - High standards in animal health to drive growth
    SPAIN
    - Growing pet population and strong dairy industry to drive market
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK
    JAPAN
    - Rising demand for animal products and increasing pet ownership to drive growth
    CHINA
    - Expanding urban pet market and high meat consumption to fuel market
    INDIA
    - Growing pet adoption and veterinary shortage to drive market
    AUSTRALIA
    - Growing pet ownership and rising spending on veterinary care to drive market
    NEW ZEALAND
    - Increased pet ownership and demand for advanced dermatology treatments to drive market
    SOUTH KOREA
    - Increasing awareness and adoption of preventive healthcare measures to drive market
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK
    BRAZIL
    - Strong veterinary infrastructure and expanding livestock industry to drive market
    MEXICO
    - Expanding livestock and poultry sectors to drive market
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Kingdom of Saudi Arabia (KSA)
    - United Arab Emirates (UAE)
    - Rest of GCC Countries
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
284
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020–2024)
  • 12.4 MARKET SHARE ANALYSIS, 2024
    RANKING OF KEY MARKET PLAYERS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Route of administration footprint
    - Product type footprint
    - Condition type footprint
    - Animal type footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 12.7 BRAND/PRODUCT COMPARISON
  • 12.8 R&D EXPENDITURE OF KEY PLAYERS
  • 12.9 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 12.10 COMPETITIVE SCENARIO
    PRODUCT APPROVALS/LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
307
  • 13.1 KEY PLAYERS
    ELANCO ANIMAL HEALTH INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK & CO., INC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VIRBAC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ZOETIS INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VETOQUINOL
    - Business overview
    - Products offered
    - Recent developments
    DECHRA PHARMACEUTICALS PLC
    - Business overview
    - Products offered
    - Recent developments
    HESTER BIOSCIENCES LIMITED
    - Business overview
    - Products offered
    PETIQ, INC.
    - Business overview
    - Products offered
    - Recent developments
    OUROFINO SAUDE ANIMAL
    - Business overview
    - Products offered
    SWEDENCARE
    - Business overview
    - Products offered
    - Recent developments
    ORION CORPORATION
    - Business overview
    - Products offered
    NORBROOK
    - Business overview
    - Products offered
    - Recent developments
    CEVA SANTE ANIMALE
    - Business overview
    - Products offered
    - Recent developments
    BIMEDA, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 13.2 OTHER PLAYERS
    INDIAN IMMUNOLOGICALS LTD.
    VETANCO
    CHANELLE PHARMA
    PEGASUS LABORATORIES, INC.
    KYORITSU SEIYAKU CORPORATION
    AVET HEALTH
    ANIMALDERMA SRLS
    LETI PHARMA
    HUVEPHARMA, INC.
    VETPLUS
APPENDIX
373
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2024
  • TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION
  • TABLE 4 MAJOR OUTBREAKS OF ZOONOTIC DISEASES, 2022–2023
  • TABLE 5 AVERAGE ANNUAL PREMIUM: US AND CANADA (USD)
  • TABLE 6 VETERINARY DERMATOLOGY MARKET: IMPACT OF PORTER’S FIVE FORCES ANALYSIS
  • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 VETERINARY DERMATOLOGY MARKET: LIST OF MAJOR PATENTS
  • TABLE 12 IMPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY, BY COUNTRY (2022–2024) (USD)
  • TABLE 13 EXPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY, BY COUNTRY (2022–2024) (USD)
  • TABLE 14 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024
  • TABLE 15 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION, 2022–2024
  • TABLE 16 VETERINARY DERMATOLOGY MARKET: KEY CONFERENCES AND EVENTS (2025−2026)
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
  • TABLE 18 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS
  • TABLE 19 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET
  • TABLE 20 VETERINARY DERMATOLOGY MARKET: IMPACT OF GENERATIVE AI
  • TABLE 21 VETERINARY DERMATOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 22 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 23 VETERINARY DERMATOLOGY MARKET: TOPICAL PRODUCTS AVAILABLE
  • TABLE 24 TOPICAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 25 VETERINARY DERMATOLOGY MARKET: INJECTABLE PRODUCTS AVAILABLE
  • TABLE 26 INJECTABLES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 27 VETERINARY DERMATOLOGY MARKET: ORAL PRODUCTS AVAILABLE
  • TABLE 28 ORAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 30 VETERINARY DERMATOLOGY MARKET: ANTIPARASITIC DRUGS AVAILABLE
  • TABLE 31 VOLUME DATA FOR ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 32 ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 VETERINARY DERMATOLOGY MARKET: ANTIFUNGAL DRUGS AVAILABLE
  • TABLE 34 ANTIFUNGAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 VETERINARY DERMATOLOGY MARKET: ANTIBACTERIAL DRUGS AVAILABLE
  • TABLE 36 ANTIBACTERIAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 VETERINARY DERMATOLOGY MARKET: MONOCLONAL ANTIBODIES AVAILABLE
  • TABLE 38 MONOCLONAL ANTIBODIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 VETERINARY DERMATOLOGY MARKET: OTHER PRODUCTS AVAILABLE
  • TABLE 40 OTHER PRODUCT TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 42 PARASITIC INFECTIONS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 INFECTIOUS DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 AUTOIMMUNE SKIN DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 SKIN CANCER: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 OTHER CONDITION TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 48 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, 2023–2030 (USD MILLION)
  • TABLE 49 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 DOGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 CATS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 HORSES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 OTHER COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 CATTLE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 56 SWINE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 POULTRY: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 OTHER LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 60 VETERINARY HOSPITALS AND CLINICS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 ANIMAL SHELTERS AND RESCUES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 OTHER END USERS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 63 VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 71 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 72 US: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 73 US: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 74 US: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 75 US: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 76 US: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 77 US: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 78 US: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 79 CANADA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 80 CANADA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 81 CANADA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 82 CANADA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 83 CANADA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 84 CANADA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 85 CANADA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 86 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 87 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 88 EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 89 EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 90 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 91 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 92 EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 93 EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 94 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 95 GERMANY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 96 GERMANY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 97 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 GERMANY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 99 GERMANY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 100 GERMANY: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 101 UK: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 102 UK: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 103 UK: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 104 UK: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 105 UK: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 106 UK: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 107 UK: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 108 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 109 FRANCE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 110 FRANCE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 111 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 112 FRANCE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 113 FRANCE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 114 FRANCE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 115 ITALY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 116 ITALY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 117 ITALY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 118 ITALY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 ITALY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 120 ITALY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 121 ITALY: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 122 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 123 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 124 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 125 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 126 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 127 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 128 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 129 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 130 SPAIN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 131 SPAIN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 133 SPAIN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 134 SPAIN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 135 SPAIN: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 136 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 151 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 152 JAPAN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 153 JAPAN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 154 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 155 JAPAN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 156 JAPAN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 157 JAPAN: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 158 CHINA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 159 CHINA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 CHINA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 161 CHINA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 CHINA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 163 CHINA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 164 CHINA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 165 INDIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 166 INDIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 167 INDIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 INDIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 169 INDIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 170 INDIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 171 INDIA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 173 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 175 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 177 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 178 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 179 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 180 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 183 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 184 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 185 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 186 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 187 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 191 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 192 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 200 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 201 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 202 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 207 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 208 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 209 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 210 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 211 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 213 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 214 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 215 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 216 MEXICO: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 217 MEXICO: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 218 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 219 MEXICO: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 220 MEXICO: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 221 MEXICO: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 222 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 223 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 224 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 229 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 237 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 244 KSA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 245 KSA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 246 KSA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 247 KSA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 248 KSA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 249 KSA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 250 KSA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 251 UAE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 252 UAE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 253 UAE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 254 UAE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 255 UAE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 256 UAE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 257 UAE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 258 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 259 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 260 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 261 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 262 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 263 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 264 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 265 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
  • TABLE 266 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 267 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)
  • TABLE 268 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 269 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 270 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)
  • TABLE 271 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 272 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET
  • TABLE 273 VETERINARY DERMATOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 274 VETERINARY DERMATOLOGY MARKET: REGION FOOTPRINT
  • TABLE 275 VETERINARY DERMATOLOGY MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
  • TABLE 276 VETERINARY DERMATOLOGY MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 277 VETERINARY DERMATOLOGY MARKET: CONDITION TYPE FOOTPRINT
  • TABLE 278 VETERINARY DERMATOLOGY MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 279 VETERINARY DERMATOLOGY MARKET: LIST OF KEY STARTUPS/SMES
  • TABLE 280 VETERINARY DERMATOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 281 VETERINARY DERMATOLOGY MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021–JANUARY 2025
  • TABLE 282 VETERINARY DERMATOLOGY MARKET: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 283 VETERINARY DERMATOLOGY MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 284 VETERINARY DERMATOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 285 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW
  • TABLE 286 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED
  • TABLE 287 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 288 ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 289 ELANCO ANIMAL HEALTH INCORPORATED: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 290 MERCK & CO., INC: COMPANY OVERVIEW
  • TABLE 291 MERCK & CO., INC: PRODUCTS OFFERED
  • TABLE 292 MERCK & CO., INC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 293 MERCK & CO., INC: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 294 MERCK & CO., INC: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 295 MERCK & CO., INC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 296 VIRBAC: COMPANY OVERVIEW
  • TABLE 297 VIRBAC: PRODUCTS OFFERED
  • TABLE 298 VIRBAC: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 299 VIRBAC: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 300 VIRBAC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 301 ZOETIS INC.: COMPANY OVERVIEW
  • TABLE 302 ZOETIS INC.: PRODUCTS OFFERED
  • TABLE 303 ZOETIS INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 304 ZOETIS INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 305 ZOETIS INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 306 ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 307 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 308 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 309 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 310 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 311 VETOQUINOL: COMPANY OVERVIEW
  • TABLE 312 VETOQUINOL: PRODUCTS OFFERED
  • TABLE 313 VETOQUINOL: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 314 DECHRA PHARMACEUTICALS PLC: COMPANY OVERVIEW
  • TABLE 315 DECHRA PHARMACEUTICALS PLC: PRODUCTS OFFERED
  • TABLE 316 DECHRA PHARMACEUTICALS PLC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 317 DECHRA PHARMACEUTICALS PLC: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 318 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW
  • TABLE 319 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED
  • TABLE 320 PETIQ, INC.: COMPANY OVERVIEW
  • TABLE 321 PETIQ, INC.: PRODUCTS OFFERED
  • TABLE 322 PETIQ, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 323 OUROFINO SAUDE ANIMAL: COMPANY OVERVIEW
  • TABLE 324 OUROFINO SAUDE ANIMAL: PRODUCTS OFFERED
  • TABLE 325 SWEDENCARE: COMPANY OVERVIEW
  • TABLE 326 SWEDENCARE: PRODUCTS OFFERED
  • TABLE 327 SWEDENCARE: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 328 ORION CORPORATION: COMPANY OVERVIEW
  • TABLE 329 ORION CORPORATION: PRODUCTS OFFERED
  • TABLE 330 NORBROOK: COMPANY OVERVIEW
  • TABLE 331 NORBROOK: PRODUCTS OFFERED
  • TABLE 332 NORBROOK: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
  • TABLE 333 NORBROOK: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 334 CEVA SANTE ANIMALE: COMPANY OVERVIEW
  • TABLE 335 CEVA SANTE ANIMALE: PRODUCTS OFFERED
  • TABLE 336 CEVA SANTE ANIMALE: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 337 BIMEDA, INC.: COMPANY OVERVIEW
  • TABLE 338 BIMEDA, INC.: PRODUCTS OFFERED
  • TABLE 339 BIMEDA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
  • TABLE 340 BIMEDA, INC.: DEALS, JANUARY 2021–JANUARY 2025
LIST OF FIGURES
 
  • FIGURE 1 VETERINARY DERMATOLOGY MARKET SCOPE AND REGIONS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION
  • FIGURE 8 REVENUE ESTIMATION APPROACH: ZOETIS INC.
  • FIGURE 9 VETERINARY DERMATOLOGY MARKET (2024): SUPPLY-SIDE ANALYSIS
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 VETERINARY DERMATOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 VETERINARY DERMATOLOGY MARKET FOR COMPANION ANIMALS, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 VETERINARY DERMATOLOGY MARKET FOR LIVESTOCK ANIMALS, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 VETERINARY DERMATOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 RISING PET POPULATION AND OWNERSHIP TO DRIVE VETERINARY DERMATOLOGY MARKET
  • FIGURE 23 ANTIPARASITIC DRUGS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, IN 2024
  • FIGURE 24 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 25 NEW ZEALAND TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 26 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH THAN EMERGING MARKETS DURING FORECAST PERIOD
  • FIGURE 27 VETERINARY DERMATOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION)
  • FIGURE 29 EUROPE: PET POPULATION, 2021–2023
  • FIGURE 30 TOTAL INSURED PETS IN US, 2019–2023
  • FIGURE 31 TOTAL INSURED PETS IN CANADA, 2019–2023
  • FIGURE 32 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER, 2020–2023
  • FIGURE 33 NUMBER OF VETERINARIANS IN TOP 5 EUROPEAN COUNTRIES, 2023
  • FIGURE 34 VETERINARY DERMATOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 35 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
  • FIGURE 36 PATENT PUBLICATION TRENDS, JANUARY 2014–DECEMBER 2024
  • FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 39 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024
  • FIGURE 40 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION, 2024
  • FIGURE 41 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
  • FIGURE 42 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS
  • FIGURE 43 VETERINARY DERMATOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 44 VETERINARY DERMATOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 45 VETERINARY DERMATOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 46 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET
  • FIGURE 47 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN VETERINARY DERMATOLOGY MARKET
  • FIGURE 48 INVESTMENT AND FUNDING ACTIVITIES IN VETERINARY DERMATOLOGY MARKET, 2020–2024
  • FIGURE 49 VETERINARY DERMATOLOGY MARKET, 2025–2030
  • FIGURE 50 GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
  • FIGURE 51 NORTH AMERICA: PET POPULATION, 2024
  • FIGURE 52 NORTH AMERICA: NUMBER OF VETERINARIANS, 2023
  • FIGURE 53 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET SNAPSHOT
  • FIGURE 54 US: TOTAL PET HEALTH EXPENDITURE (2018–2024)
  • FIGURE 55 EUROPE: PET POPULATION (MILLION), 2023
  • FIGURE 56 EUROPE: NUMBER OF VETERINARIANS, 2022
  • FIGURE 57 ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024
  • FIGURE 58 ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024
  • FIGURE 59 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET SNAPSHOT
  • FIGURE 60 LATIN AMERICA: PET POPULATION, 2022
  • FIGURE 61 MIDDLE EAST & AFRICA: CAT POPULATION, 2024
  • FIGURE 62 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020−2024)
  • FIGURE 63 SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2024)
  • FIGURE 64 RANKING OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2024
  • FIGURE 65 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX, 2024
  • FIGURE 66 VETERINARY DERMATOLOGY MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 67 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 68 VETERINARY DERMATOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 69 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2021−2023
  • FIGURE 70 EV/EBITDA FOR TOP COMPANIES
  • FIGURE 71 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 72 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 73 MERCK & CO., INC: COMPANY SNAPSHOT (2024)
  • FIGURE 74 VIRBAC: COMPANY SNAPSHOT (2023)
  • FIGURE 75 ZOETIS INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 76 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • FIGURE 77 VETOQUINOL: COMPANY SNAPSHOT (2023)
  • FIGURE 78 DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 79 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 80 PETIQ, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 81 OUROFINO SAUDE ANIMAL: COMPANY SNAPSHOT (2023)
  • FIGURE 82 SWEDENCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 83 ORION CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 84 NORBROOK: COMPANY SNAPSHOT (2023)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the veterinary dermatology market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, chief medical information officers related to the veterinary dermatology markets. Primary sources from the demand side include professionals from veterinary hospitals and clinics, academic & research institutes, pet owners and livestock farm owners.

A breakdown of the primary respondents is provided below:

Veterinary Dermatology Market

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2023: Tier 1 = >USD 500 million, Tier 2 = USD 200 million to USD 500 million, and Tier 3 = < USD 200 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary dermatology market was arrived at after data triangulation from three different approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach

Veterinary Dermatology Market

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in the market engineering process.

Market Definition

Veterinary dermatology focuses on therapeutic products for managing dermatological conditions in animals, including allergies, infections, irritations, parasitic infestations, atopic dermatitis, skin cancer, and chronic skin disorders. It serves both companion and livestock animals with treatments like topical solutions, oral medications, and injectables. These products aim to treat various dermatological diseases and enhance the coat quality, skin health, and the overall well-being of the animal.

Stakeholders

  • Manufacturing companies of veterinary dermatology products
  • Distributors of products associated with veterinary dermatology diseases
  • Veterinary hospitals and clinics
  • Veterinary practitioners
  • Veterinary consultants
  • Medical research institutes
  • Market research and consulting firms
  • Venture capitalists and investors
  • egulatory agencies and government bodies

Report Objectives

  • To define, describe, and forecast the veterinary dermatology market by route of administration, product type, condition type, animal type, end user, and region
  • To provide detailed information about the key factors, such as drivers, restraints, opportunities, challenges, and industry trends, influencing the market growth
  • To strategically analyze the regulatory scenario, value chain analysis, supply chain analysis, Porter’s Five Forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, impact of AI on veterinary dermatology market, case study analysis, adjacent market analysis, unmet needs/end user expectations in veterinary dermatology market, and trends/disruption impacting customer business in the market
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To strategically analyze the market in five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches and approvals, acquisitions, partnerships, collaborations, and expansions in the market

Previous Versions of this Report

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Veterinary Dermatology Market

DMCA.com Protection Status